← Back to Search

Time Restricted Eating for Aging

N/A
Recruiting
Led By Stephen Anton, Ph.D.
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessing change between baseline and week 8
Awards & highlights

Study Summary

This trial aims to explore how changing meal times can affect metabolism & circadian rhythms in older adults, to improve cellular health & function.

Who is the study for?
This trial is for men and women aged 65 or older who are overweight, have difficulty walking or climbing stairs, do not exercise much (less than 150 minutes of structured exercise per week), and can walk unassisted. They should not be actively trying to lose weight through other programs, must not have diabetes, unstable heart conditions, certain severe diseases like Parkinson's or rheumatoid arthritis, or be on treatments that prevent fasting for 16 hours.Check my eligibility
What is being tested?
The FAR Phase 2 Study is testing how time-restricted eating affects the body's fuel metabolism and internal clock in older adults. The goal is to find easy ways to measure changes in these areas after following a diet that limits when participants can eat during the day.See study design
What are the potential side effects?
Since this study involves dietary intervention with time-restricted eating rather than medication, side effects may include hunger outside of eating windows, potential changes in energy levels throughout the day, and possibly digestive discomfort as the body adjusts to new eating schedules.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessing change between baseline and week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessing change between baseline and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Cellular Fuel Utilization
Change in Heart rate will be assessed by the Oura ring.
Change in activity level will be assessed by the Oura ring.
+11 more
Secondary outcome measures
Chang in Cognitive Function - Attention
Change in Body Composition
Change in Cognitive Function - Inhibitory Control
+7 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Time Restricted Eating interventionExperimental Treatment1 Intervention
Participants will be asked to stop eating by 7 PM every day and to fast for a target of 16 hours per day for 8 weeks. During the first two weeks of the intervention, participants will gradually ramp up to a full 16-hour fasting period (Week 1 - fast for 12-14 hours per day, Week 2 - fast for 14-16 hours per day, Week 3 - 8 - fast for 16 hours per day). Participants will be allowed to consume calorie-free beverages, tea, black coffee, sugar-free gum, and they will be encouraged to drink plenty of water throughout the entire intervention period. Additionally, they will be asked to keep a Fasting and Sleeping diary logging their eating habits and sleep quality.

Find a Location

Who is running the clinical trial?

Florida Department of HealthOTHER_GOV
28 Previous Clinical Trials
12,988 Total Patients Enrolled
1 Trials studying Aging
46 Patients Enrolled for Aging
University of FloridaLead Sponsor
1,341 Previous Clinical Trials
715,631 Total Patients Enrolled
28 Trials studying Aging
3,387 Patients Enrolled for Aging
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,870 Total Patients Enrolled
160 Trials studying Aging
75,992 Patients Enrolled for Aging

Media Library

Time Restricted Eating Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05482711 — N/A
Aging Research Study Groups: Time Restricted Eating intervention
Aging Clinical Trial 2023: Time Restricted Eating Intervention Highlights & Side Effects. Trial Name: NCT05482711 — N/A
Time Restricted Eating Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05482711 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is access to this research opportunity currently available for participants?

"This clinical research project appears to be actively recruiting based on the details provided by clinicaltrials.gov. It was first posted on October 10th 2023, and more recently updated on April 5th of this same year."

Answered by AI

How many participants are currently engaged in this therapeutic research?

"Affirmative. The clinicaltrials.gov website conveys that this medical trial is actively recruiting participants, having initially been posted on January 10th, 2023 and most recently updated April 5th, 2023. 15 patients need to be recruited from a single site for the study's completion."

Answered by AI

What beneficial effects are researchers hoping to observe as a result of this clinical trial?

"The primary metric under investigation is the shift in circadian rhythm gene CLOCK. Additionally, researchers will assess changes in cognitive function (memory) through a valid battery from NIH Toolbox, physical capabilities with Short Physical Performance Battery tests administrated by experts, and anthropometric measurements such as height/weight to calculate BMI plus waist circumference taken at mid-point between rib and hip bone over an 8 week period."

Answered by AI
Recent research and studies
~9 spots leftby Dec 2025